Melatonin Versus Placebo in Breast Cancer

Completed · Early Phase 1 · Has a placebo group

Conditions studied: Breast Cancer

In brief

The purpose of this research study is to determine whether melatonin taken every night can affect blood levels of estrogen or IGF (insulin-growth factor levels). Both IGF and estrogen are normally produced in the body and may influence breast cancer risk. Melatonin is also naturally produced in the body. Laboratory studies have shown that melatonin may decrease cancer growth and influence estrogen and IGF levels. Melatonin's effects on sleep, hot flashes, and mood will also be measured.

Key facts

Study ID

NCT01805089

Run by

Dana-Farber Cancer Institute

People needed

95

Starts

2006-10-01

Expected to finish

2009-07-01

Last updated by the study team

2015-03-23

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• History of ductal carcinoma in situ, lobular carcinoma in situ or stages 1-3 breast cancer
• Not currently receiving chemotherapy or hormonal therapy
• Postmenopausal

You may not qualify if…

• Stage IV breast cancer or systemic recurrences
• Prior malignancies of any type other than breast cancer, basal or squamous cell carcinoma of the skin or carcinoma in situ of the cervix
• Use of adjuvant hormonal therapy, oral estrogen or progesterone replacement therapy, lutenizing hormone releasing hormone agonists currently or within the past 60 days
• Concomitant use of beta-blockers
• Concomitant nightly use of sleep aids at bedtime
• Working more than one overnight shift per month on a regular basis
• Concomitant use of postmenopausal hormone replacement therapy
• Concomitant use of black cohosh, flaxseed or soy in pill or supplement form
• Use of any type of oral melatonin supplementation within the past 30 days
• Use of warfarin (coumadin) within the past 30 days
• Active seizure disorder requiring the use of daily anti-epileptic medication

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.